MMWR Morb Mortal Wkly Rep. 2012 Aug 17;61(32):613-8.
In 2010, the Advisory Committee on Immunization Practices (ACIP) first recommended annual influenza vaccination for all persons aged ≥6 months in the United States (1). Annual influenza vaccination of all persons aged ≥6 months continues to be recommended. This document 1) describes influenza vaccine virus strains included in the U.S. seasonal influenza vaccine for 2012-13; 2) provides guidance for the use of influenza vaccines during the 2012-13 season, including an updated vaccination schedule for children aged 6 months through 8 years and a description of available vaccine products and indications; 3) discusses febrile seizures associated with administration of influenza and 13-valent pneumococcal conjugate (PCV-13) vaccines; 4) provides vaccination recommendations for persons with a history of egg allergy; and 5) discusses the development of quadrivalent influenza vaccines for use in future influenza seasons. Information regarding issues related to influenza vaccination that are not addressed in this update is available in CDC's Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010 and associated updates (1,2).
2010 年，免疫实践咨询委员会（ACIP）首次建议美国所有≥6 月龄人群每年接种流感疫苗（1）。目前仍建议所有≥6 月龄人群每年接种流感疫苗。本文件 1）描述了 2012-13 年美国季节性流感疫苗中包含的流感疫苗病毒株；2）提供了 2012-13 年流感疫苗使用指南，包括儿童（6 月龄至 8 岁）更新的疫苗接种时间表和可用疫苗产品及适应证的描述；3）讨论了与流感和 13 价肺炎球菌结合疫苗（PCV-13）接种相关的发热性惊厥；4）为有鸡蛋过敏史的人群提供了疫苗接种建议；5）讨论了未来流感季节使用四价流感疫苗的情况。本更新未涉及与流感疫苗接种相关的其他信息，可查阅 CDC 的《疫苗预防和控制流感：免疫实践咨询委员会（ACIP）建议，2010 年及相关更新》（1,2）。
